BMS Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$347K Sell
1,561
-664
-30% -$154K 0.23% 84
2023
Q1
$538K Sell
2,225
-19
-0.8% -$4.66K 0.37% 61
2022
Q4
$589K Sell
2,244
-70
-3% -$18.8K 0.39% 45
2022
Q3
$522K Sell
2,314
-31
-1% -$7.51K 0.37% 54
2022
Q2
$571K Buy
2,345
+89
+4% +$21.8K 0.37% 46
2022
Q1
$546K Buy
+2,256
New +$518K 0.35% 58

Other funds holding AMGN

BMS Financial Advisors's AMGN Position: Q2 2023 in Review

BMS Financial Advisors reduced its Amgen (AMGN) stake by 30% in Q2 2023, selling an estimated $154K and leaving 1,561 shares worth $347K. The position accounts for 0.23% of the portfolio, ranked #84.

BMS Financial Advisors first reported a position in AMGN in Q1 2022 and has held it in 6 quarters since. The position peaked at $589K in Q4 2022. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • BMS Financial Advisors held 1,561 shares of Amgen worth $347K as of Q2 2023.
  • BMS Financial Advisors sold 664 Amgen shares in Q2 2023, an estimated $154K.
  • Amgen made up 0.23% of BMS Financial Advisors's portfolio in Q2 2023, its #84 holding.
  • BMS Financial Advisors first reported a position in Amgen in Q1 2022 and has held it in 6 quarters since.
  • BMS Financial Advisors's Amgen position peaked at $589K in Q4 2022.
  • 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on BMS Financial Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.